Dios Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2011.
2011 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Dios Pharmaceuticals Private Limited

Dios Pharmaceuticals Private Limited, a active private limited company, was established on 09 August 2011 in New Delhi, Delhi, India. Engaging in retail trading within the trade sector, it holds CIN: U24232DL2011PTC223493. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Rini Samuel (Director), Vinod Kumar (Director). Past directors included Vineet Sagar, Anil Kumar. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Rz-B, Kh No.13/6/1 Sita Puri-1,, New Delhi, Delhi, 110045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2011PTC223493

  • Registration Number

    223493

  • Incorporation Date

    09 August 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 28.57%
  • Ebitda ****
  • Net Worth -14.53%
  • Total Assets **** %
Company report

Dios Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dios Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dios Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rini Samuel Director 08 Sep 2015 Current
Vinod Kumar Director 09 Aug 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Sep 2015 Past
Pramod Abcsdd Director 15 May 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dios Pharmaceuticals.

Dios Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 28.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.53%.

Dios Pharmaceuticals revenue growth over time
Dios Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
 28.57%
*******
*******
*******
*******
Net Worth
*******
 -14.53%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dios Pharmaceuticals?

In 2017, Dios Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dios Pharmaceuticals?

Unlock and access historical data on people associated with Dios Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dios Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dios Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dios Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Dios Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Dios Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    The activity Rini Samuel was appointed as a Director was appointed as a Director on 08 Sep 2015 & has been associated with this company since 10 years 5 months . was completed.

  • Director Appointment

    The activity Vinod Kumar was appointed as a Director was appointed as a Director on 09 Aug 2011 & has been associated with this company since 14 years 6 months . was completed.

  • Company Incorporation

    The activity Dios Pharmaceuticals Private Limited was registered on 09 Aug 2011 with Roc Delhi & aged 14 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dios Pharmaceuticals Private Limited?

The CIN of Dios Pharmaceuticals Private Limited is U24232DL2011PTC223493.

Where is Dios Pharmaceuticals Private Limited headquartered?

Dios Pharmaceuticals Private Limited is headquartered at Rz-B, Kh No.13/6/1 Sita Puri-1,, New Delhi, Delhi, 110045.

When was Dios Pharmaceuticals Private Limited incorporated?

Dios Pharmaceuticals Private Limited was incorporated on 09 August 2011.

Who are the current directors of Dios Pharmaceuticals Private Limited?

The current directors of Dios Pharmaceuticals Private Limited are

What is the primary industry of Dios Pharmaceuticals Private Limited?

The primary industry of Dios Pharmaceuticals Private Limited is Trade.

Is Dios Pharmaceuticals Private Limited a listed company?

Dios Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dios Pharmaceuticals Private Limited?

The authorized capital of Dios Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Dios Pharmaceuticals Private Limited?

The compliance status of Dios Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available